Guobei Yan

1.1k total citations · 1 hit paper
7 papers, 1.0k citations indexed

About

Guobei Yan is a scholar working on Materials Chemistry, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Guobei Yan has authored 7 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Materials Chemistry, 4 papers in Biomedical Engineering and 3 papers in Molecular Biology. Recurrent topics in Guobei Yan's work include Nanocluster Synthesis and Applications (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Advanced Nanomaterials in Catalysis (4 papers). Guobei Yan is often cited by papers focused on Nanocluster Synthesis and Applications (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Advanced Nanomaterials in Catalysis (4 papers). Guobei Yan collaborates with scholars based in China and United States. Guobei Yan's co-authors include Zilong Zhao, Weihong Tan, Huanhuan Fan, Xiaobing Zhang, Xiaoxiao Hu, Xiaoyi Fu, Hui Liu, Ting Fu, Wenhan Zhang and Hui Liu and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and RSC Advances.

In The Last Decade

Guobei Yan

7 papers receiving 1.0k citations

Hit Papers

A Smart Photosensitizer–Manganese Dioxide Nanosystem for ... 2016 2026 2019 2022 2016 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guobei Yan China 6 755 592 407 184 174 7 1.0k
Yongxin Li China 15 610 0.8× 602 1.0× 347 0.9× 183 1.0× 325 1.9× 23 1.1k
Qianglan Lu China 19 725 1.0× 443 0.7× 270 0.7× 104 0.6× 226 1.3× 30 975
Keunsoo Jeong South Korea 14 458 0.6× 433 0.7× 186 0.5× 201 1.1× 215 1.2× 21 886
Huarong Bai China 10 661 0.9× 497 0.8× 717 1.8× 100 0.5× 212 1.2× 15 1.2k
Fangmian Wei China 12 630 0.8× 452 0.8× 175 0.4× 275 1.5× 89 0.5× 14 860
Liyi Ma China 14 547 0.7× 345 0.6× 306 0.8× 73 0.4× 189 1.1× 21 870
Mingwan Shi China 13 681 0.9× 401 0.7× 288 0.7× 120 0.7× 161 0.9× 28 902
Yeneng Dai China 14 1.0k 1.4× 600 1.0× 286 0.7× 264 1.4× 258 1.5× 20 1.2k
Yudi Ruan China 9 707 0.9× 601 1.0× 155 0.4× 138 0.8× 148 0.9× 10 895
Sensen Zhou China 14 508 0.7× 250 0.4× 237 0.6× 85 0.5× 216 1.2× 27 806

Countries citing papers authored by Guobei Yan

Since Specialization
Citations

This map shows the geographic impact of Guobei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobei Yan more than expected).

Fields of papers citing papers by Guobei Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guobei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobei Yan. The network helps show where Guobei Yan may publish in the future.

Co-authorship network of co-authors of Guobei Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Guobei Yan. A scholar is included among the top collaborators of Guobei Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guobei Yan. Guobei Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Liu, Hongbin, et al.. (2019). Knockdown of USP14 inhibits PDGF-BB-induced vascular smooth muscle cell dedifferentiationviainhibiting mTOR/P70S6K signaling pathway. RSC Advances. 9(63). 36649–36657. 10 indexed citations
2.
Fan, Huanhuan, Lili Zhang, Xiaoxiao Hu, et al.. (2018). An MTH1-targeted nanosystem for enhanced PDT via improving cellular sensitivity to reactive oxygen species. Chemical Communications. 54(34). 4310–4313. 28 indexed citations
3.
Fan, Huanhuan, Guobei Yan, Zilong Zhao, et al.. (2016). A Smart Photosensitizer–Manganese Dioxide Nanosystem for Enhanced Photodynamic Therapy by Reducing Glutathione Levels in Cancer Cells. Angewandte Chemie. 128(18). 5567–5572. 82 indexed citations
4.
Fan, Huanhuan, Guobei Yan, Zilong Zhao, et al.. (2016). Rücktitelbild: A Smart Photosensitizer–Manganese Dioxide Nanosystem for Enhanced Photodynamic Therapy by Reducing Glutathione Levels in Cancer Cells (Angew. Chem. 18/2016). Angewandte Chemie. 128(18). 5702–5702. 5 indexed citations
5.
Fan, Huanhuan, Guobei Yan, Zilong Zhao, et al.. (2016). A Smart Photosensitizer–Manganese Dioxide Nanosystem for Enhanced Photodynamic Therapy by Reducing Glutathione Levels in Cancer Cells. Angewandte Chemie International Edition. 55(18). 5477–5482. 528 indexed citations breakdown →
6.
Fan, Huanhuan, Zilong Zhao, Guobei Yan, et al.. (2015). A Smart DNAzyme–MnO 2 Nanosystem for Efficient Gene Silencing. Angewandte Chemie International Edition. 54(16). 4801–4805. 296 indexed citations
7.
Fan, Huanhuan, Zilong Zhao, Guobei Yan, et al.. (2015). A Smart DNAzyme–MnO2 Nanosystem for Efficient Gene Silencing. Angewandte Chemie. 127(16). 4883–4887. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026